低分化甲状腺癌
也被称为:低分化甲状腺癌/岛癌(形态学异常)
| 药物 | 药物名称 | 药物的描述 |
|---|
| 药物 | 药物名称 | 目标 | 类型 |
|---|
| 药物 | 药物名称 | 阶段 | 状态 | 数 |
|---|---|---|---|---|
| DB00062 | 白蛋白人类 | 2 | 积极不招聘 | 1 |
| DB00041 | Aldesleukin | 2 | 积极不招聘 | 1 |
| DB11595 | Atezolizumab | 2 | 积极不招聘 | 1 |
| DB00112 | 贝伐单抗 | 2 | 积极不招聘 | 1 |
| DB08875 | Cabozantinib | 2 | 积极不招聘 | 1 |
| DB08875 | Cabozantinib | 2 | 完成 | 1 |
| DB08875 | Cabozantinib | 2 | 终止 | 1 |
| DB00515 | 顺铂 | 2 | 未知的状态 | 1 |
| DB05239 | Cobimetinib | 2 | 积极不招聘 | 1 |
| DB00531 | 环磷酰胺 | 2 | 积极不招聘 | 1 |
| DB08912 | Dabrafenib | 2 | 积极不招聘 | 1 |
| DB01073 | 氟达拉滨 | 2 | 积极不招聘 | 1 |
| DB09293 | 碘化i - 131 | 2 | 积极不招聘 | 1 |
| DB06186 | Ipilimumab | 2 | 积极不招聘 | 2 |
| DB09078 | Lenvatinib | 2 | 积极不招聘 | 1 |
| DB09078 | Lenvatinib | 2 | 招聘 | 1 |
| DB09078 | Lenvatinib | 2 | 暂停 | 1 |
| DB09078 | Lenvatinib | 2 | 终止 | 1 |
| DB17107 | Lifileucel | 2 | 积极不招聘 | 1 |
| DB09035 | Nivolumab | 2 | 积极不招聘 | 2 |
| DB01229 | 紫杉醇 | 2 | 积极不招聘 | 1 |
| DB09037 | Pembrolizumab | 2 | 积极不招聘 | 1 |
| DB09037 | Pembrolizumab | 2 | 招聘 | 1 |
| DB09037 | Pembrolizumab | 2 | 暂停 | 1 |
| DB15685 | Selpercatinib | 2 | 招聘 | 1 |
| DB11689 | Selumetinib | 2 | 积极不招聘 | 1 |
| DB00398 | 索拉非尼 | 2 | 终止 | 1 |
| DB14892 | Spartalizumab | 2 | 积极不招聘 | 1 |
| DB08911 | Trametinib | 2 | 积极不招聘 | 2 |
| DB05294 | Vandetanib | 2 | 终止 | 1 |
| DB08881 | Vemurafenib | 2 | 积极不招聘 | 1 |